Can Marcus & Millichap's (MMI) Growth Investments Outpace Rising Losses?

Simply Wall St.
08/11
  • Marcus & Millichap reported second quarter 2025 results showing revenue increased to US$172.28 million from US$158.37 million a year earlier, while net loss also widened to US$11.04 million from US$5.54 million the previous year.
  • Despite sustained revenue growth, the company's leadership highlighted ongoing efforts to pursue acquisitions aimed at scaling their core business and expanding into complementary segments.
  • We’ll review how the combination of increased revenue with a wider net loss may influence Marcus & Millichap’s long-term investment case.

The end of cancer? These 26 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.

Advertisement

Marcus & Millichap Investment Narrative Recap

To be a shareholder in Marcus & Millichap, you have to believe in a rebound in commercial real estate transactions and the company's potential to expand via acquisitions, offsetting near-term earnings declines. The recent Q2 results, showing higher revenue but a wider net loss, highlight that while top-line growth continues, profitability is still challenged. This news has not materially changed the biggest catalyst, which remains a recovery in transaction volume, or the risk posed by transaction-dependent earnings.

Among recent announcements, the affirmation of a semi-annual dividend of US$0.25 per share stands out. Even with persistent net losses, the continued dividend may interest investors seeking income, though it highlights the tension between rewarding shareholders now and funding expenses as revenues recover.

On the other hand, investors should be aware that volatility in transaction activity continues to expose Marcus & Millichap to ...

Read the full narrative on Marcus & Millichap (it's free!)

Marcus & Millichap's outlook forecasts $1.1 billion in revenue and $64.4 million in earnings by 2028. This assumes annual revenue growth of 15.9% and a $71.2 million increase in earnings from the current -$6.8 million.

Uncover how Marcus & Millichap's forecasts yield a $30.00 fair value, a 3% upside to its current price.

Exploring Other Perspectives

MMI Earnings & Revenue Growth as at Aug 2025

Private investors in the Simply Wall St Community see Marcus & Millichap’s fair value between US$54.66 and US$68.76, based on two distinct estimates. Despite this, transaction-dependent earnings volatility remains a focal point for your ongoing research.

Explore 2 other fair value estimates on Marcus & Millichap - why the stock might be worth just $54.66!

Build Your Own Marcus & Millichap Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

  • A great starting point for your Marcus & Millichap research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
  • Our free Marcus & Millichap research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Marcus & Millichap's overall financial health at a glance.

No Opportunity In Marcus & Millichap?

Our top stock finds are flying under the radar-for now. Get in early:

  • Trump has pledged to "unleash" American oil and gas and these 22 US stocks have developments that are poised to benefit.
  • We've found 19 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.
  • Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10